drugset / Trial / NCT07657455

Daily Versus Alternate-Day Oral Iron Therapy for Anemia in Second-Trimester Pregnancy

NCT07657455

Not yet recruiting 184 enrolled Pakistan Air Force (PAF) Hospital Islamabad
RandomizedParallel-groupSingle-blindTreatment

Summary

This randomized controlled trial compares daily versus alternate-day oral iron supplementation in pregnant women with iron deficiency anemia during the second trimester. The study evaluates changes in hemoglobin and serum ferritin, treatment adherence, and gastrointestinal side effects to inform more patient-centered, physiologically aligned dosing strategies.

Timeline

Start
2026-09
Primary completion
2026-12
Completion
2027-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Ferrous Sulfate Diagnostic / imaging agent 325 mg Oral
Subject Ferrous Sulfate Diagnostic / imaging agent 650 mg Oral